Clare Bradley, professor of Health Psychology, Head of the Health Psychology Research Unit (HPRU) and CEO of Health Psychology Research (HPR) Ltd at Royal Holloway, University of London, is a finalist for the EU Prize for Women Innovators, 2018.
Clare Bradley, CEO Health Psychology Ltd.
With the winner to be announced towards the end of June, Clare’s achievement arose from the success of her business, HPR Ltd., which has made the products of her research available for others to use. She is the only UK finalist selected for this year’s prize.
The Royal Holloway HPRU specialises in the development and use of quality of life, treatment satisfaction and other Patient Reported Outcome Measures (PROMs) in international health-related research.
PROMs developed by Clare and her HPRU were originally licensed to others with the help of the College’s Research and Enterprise Unit, but as demand grew it became necessary to make other arrangements.
Clare founded HPR Ltd. in 2003, to manage the licensing of her PROMs and to drive the gold-standard linguistic validation work needed to produce high quality versions of the questionnaires in other languages.
Widespread use of these PROMs by pharmaceutical companies in multi-national clinical trials has helped to provide language versions for use by clinicians, academics and students in their research and in clinical practice.
Now in over 120 languages, Clare’s PROMs are used worldwide in clinical trials and clinical practice to assess outcomes that are important to patients, thereby humanising medicine and medical practice.
Clare says: “I am delighted to be a finalist for the EU Prize for Women Innovators.
“If treatments for long-term conditions are going to be useable in the long term, they need to protect and/or improve quality of life.
“We now have 60 different PROMs covering more than 12 different long-term conditions for patients in age groups from 5 years of age and they are used by all the major pharmaceutical companies and many others.
“Our condition-specific quality of life measures can be used to compare outcomes of different treatments on patients with different conditions, judging the real value of those treatments, taking account of their impact on quality of life and not just on health status.
“It’s great to gain recognition for the work that I am doing with my dedicated colleagues at HPR Ltd to promote optimal worldwide use of the PROMs developed by my expert research team in HPRU. There is impressive competition for the EU prize, and whatever the outcome on the night, the 12 influential businesswomen who are the finalists are all winners.”
The awards will be presented on 21 June 2018, at the POLITICO’s Women Rule Summit, in Brussels, Belgium.